Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1807 studies found for:    "Hepatitis C"
Show Display Options
RSS Create an RSS feed from your search for:
"Hepatitis C"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Hepatitis C Testing in VA Community-Based Outpatient Clinics
Condition: Hepatitis C
Intervention: Other: QI
2 Completed Australian Trial in Acute Hepatitis C
Condition: Hepatitis C
Interventions: Drug: Pegylated Interferon alfa 2a;   Drug: Ribavirin (HIV conifected patients only)
3 Completed Undiagnosed Hepatitis C Infection in an Urban Hospital
Condition: Hepatitis C
Intervention: Other: Observation only, no intervention
4 Completed Pegaferon and Ribavirin for Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Pegaferon (pegylated interferon alpha 2a) + ribavirin
5 Completed
Has Results
Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C
Condition: Hepatitis C
Interventions: Drug: BMS-790052 (NS5A Replication Complex Inhibitor);   Drug: Placebo matching BMS-790052;   Drug: Pegylated-interferon alfa 2a;   Drug: Ribavirin
6 Completed Fluvastatin Versus Hepatitis C Virus
Condition: Hepatitis C
Intervention: Drug: fluvastatin
7 Completed
Has Results
Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients
Condition: Hepatitis C
Intervention: Drug: Alisporivir
8 Completed Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects
Condition: Hepatitis C
Interventions: Drug: EDP239;   Drug: Placebo
9 Completed A Phase 3 Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) Patients
Condition: Hepatitis C
Interventions: Drug: BMS-790052 (Daclatasvir);   Drug: BMS-650032 (Asunaprevir)
10 Completed
Has Results
Safety and Efficacy of MP-424 to Treat Chronic Hepatitis C
Condition: Hepatitis C
Intervention: Drug: MP-424 (Telaprevir)
11 Completed
Has Results
Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation
Condition: Hepatitis C
Interventions: Drug: Cyclosporine;   Drug: Tacrolimus
12 Not yet recruiting The Prime Study - Comparing Hepatitis C Care and Treatment in a Primary Health Care Service With a Tertiary Hospital
Condition: Hepatitis C
Intervention: Other: community based hepatitis C care and treatment
13 Recruiting An Observational/Non-interventional, Study of NS3/4a Protease and NS5A Protein of Hepatitis C Virus in Brazilian Participants With Chronic HCV Infection
Condition: Hepatitis C Virus
Intervention:
14 Completed A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
Condition: Hepatitis C
Interventions: Drug: GSK2336805 10mg;   Drug: GSK2336805 30mg;   Drug: GSK2236805 100mg;   Drug: GSK2236805 200mg;   Drug: GSK2236805 10mg;   Drug: GSK2236805 dose to be determined up to 100mg;   Drug: GSK2236805 5mg;   Drug: GSK2236805 30mg
15 Terminated
Has Results
Pegylated Interferon, Ribavirin, Telaprevir in Hepatitis C Virus Infection in Orthotopic Liver Transplant Recipients
Condition: Hepatitis C
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin;   Drug: telaprevir
16 Active, not recruiting Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis
Condition: Hepatitis C
Interventions: Drug: Simeprivir (SMV);   Drug: Sofosbuvir (SOF);   Drug: Ribavirin (RBV)
17 Completed
Has Results
A Study to Assess the Anti-viral Activity, Safety, Tolerability and Pharmacokinetics of TMC435350 in Participants Infected With Hepatitis C-Virus (HCV)
Condition: Hepatitis C
Intervention: Drug: TMC435
18 Withdrawn Rosuvastatin for Hepatitis C
Condition: Hepatitis C
Intervention: Drug: rosuvastatin
19 Recruiting Prevalence and Screening of Hepatitis C in Belgium in 2015
Condition: Hepatitis C
Interventions: Other: Questionnaire;   Procedure: HCV serology
20 Completed Effects of Silybum Marianum on Treatment of Patients With Chronic Hepatitis C
Condition: Hepatitis C
Intervention: Drug: Silymarin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.